Tenecteplase Non-inferior to Alteplase in Stroke: ATTEST-2 Tenecteplase Non-inferior to Alteplase in Stroke: ATTEST-2

This result, along with its ease of use, adds to the growing evidence that tenecteplase should be a first-line thrombolytic agent, trial investigators say.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news